Free Trial

Axsome Therapeutics (AXSM) SEC Filings & 10K Form

Axsome Therapeutics logo
$97.95 +0.12 (+0.12%)
(As of 12:00 PM ET)

Recent Axsome Therapeutics SEC Filings

DateFilerForm TypeView
11/12/2024
8:43 AM
Axsome Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2024
5:23 PM
Axsome Therapeutics (Issuer)
Maizel Ari (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
10/01/2024
4:24 PM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2024
6:00 PM
Axsome Therapeutics (Issuer)
Saad Mark E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/11/2024
3:32 PM
Axsome Therapeutics (Subject)
Saad Mark E (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
09/04/2024
6:05 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/21/2024
6:05 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/09/2024
6:27 PM
Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2024
6:05 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
3:30 PM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/11/2024
3:30 PM
Axsome Therapeutics (Issuer)
Saad Mark E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:31 PM
Axsome Therapeutics (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:31 PM
Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/11/2024
3:32 PM
Axsome Therapeutics (Issuer)
Mahony Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/05/2024
6:38 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/29/2024
7:11 PM
Axsome Therapeutics (Issuer)
Axsome Therapeutics (Issuer)
Coleman Mark (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
7:12 PM
Axsome Therapeutics (Issuer)
Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
3:28 PM
Axsome Therapeutics (Subject)
Coleman Mark (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/06/2024
4:20 PM
Axsome Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2024
6:05 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/01/2024
5:46 PM
Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2024
5:14 PM
Axsome Therapeutics (Subject)
Jacobson Mark L. (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
04/01/2024
7:27 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
8:02 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/25/2024
8:06 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2024
6:06 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/15/2024
7:05 PM
Axsome Therapeutics (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/15/2024
6:09 PM
Axsome Therapeutics (Subject)
JEFFS ROGER (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/29/2024
5:25 PM
Axsome Therapeutics (Issuer)
Pizzie Nick (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
5:34 PM
Axsome Therapeutics (Issuer)
Jacobson Mark L. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
5:34 PM
Axsome Therapeutics (Issuer)
Saad Mark E (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
5:34 PM
Axsome Therapeutics (Issuer)
JEFFS ROGER (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
5:18 PM
Axsome Therapeutics (Issuer)
Mahony Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
5:20 PM
Axsome Therapeutics (Issuer)
TABUTEAU HERRIOT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/29/2024
4:39 PM
Axsome Therapeutics (Issuer)
Murdock Hunter R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/23/2024
7:10 AM
Axsome Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/20/2024
6:05 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
2:46 PM
Axsome Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
Form SC 13G/A
02/14/2024
6:26 AM
Axsome Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
Form SC 13G/A
01/08/2024
6:10 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/04/2024
6:11 AM
Axsome Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
DeFi Coin on Verge of Breakout! (Ad)

The blueprint for millionaires is here. Don't let this be the missed opportunity you regret for years.

Claim your FREE book now before it's too late!
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:AXSM) was last updated on 11/14/2024 by MarketBeat.com Staff
From Our Partners